Shares of hVIVO plc (LON:HVO – Get Free Report) rose 10% during trading on Monday . The company traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). Approximately 7,804,669 shares changed hands during mid-day trading, an increase of 164% from the average daily volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Stock Performance
The firm’s 50-day moving average price is GBX 20.01 and its 200 day moving average price is GBX 25.58. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61. The company has a market cap of £129.27 million, a price-to-earnings ratio of 633.33 and a beta of 0.97.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Further Reading
- Five stocks we like better than hVIVO
- How to Use the MarketBeat Excel Dividend Calculator
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Steel Stocks Soaring After Tariff Announcements
- ESG Stocks, What Investors Should Know
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
